Connection

TETSUO ASHIZAWA to Molecular Sequence Data

This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Molecular Sequence Data.
Connection Strength

0.457
  1. SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS One. 2015; 10(8):e0135906.
    View in: PubMed
    Score: 0.085
  2. The role of ataxin 10 in the pathogenesis of spinocerebellar ataxia type 10. Neurology. 2006 Aug 22; 67(4):607-13.
    View in: PubMed
    Score: 0.046
  3. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000 Oct; 26(2):191-4.
    View in: PubMed
    Score: 0.030
  4. De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet. 1995 May; 56(5):1067-74.
    View in: PubMed
    Score: 0.021
  5. CAG repeat size and clinical presentation in Huntington's disease. Neurology. 1994 Jun; 44(6):1137-43.
    View in: PubMed
    Score: 0.020
  6. Mapping of the polypeptide chain organization of the main extracellular domain of the alpha-subunit in membrane-bound acetylcholine receptor by antipeptide antibodies spanning the entire domain. Adv Exp Med Biol. 1994; 347:221-8.
    View in: PubMed
    Score: 0.019
  7. Effects of the sex of myotonic dystrophy patients on the unstable triplet repeat in their affected offspring. Neurology. 1994 Jan; 44(1):120-2.
    View in: PubMed
    Score: 0.019
  8. Somatic instability of CTG repeat in myotonic dystrophy. Neurology. 1993 Dec; 43(12):2674-8.
    View in: PubMed
    Score: 0.019
  9. Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
    View in: PubMed
    Score: 0.018
  10. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron. 2012 Aug 09; 75(3):437-50.
    View in: PubMed
    Score: 0.017
  11. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Proc Natl Acad Sci U S A. 1992 Jul 01; 89(13):5852-6.
    View in: PubMed
    Score: 0.017
  12. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012 Jan 26; 1(1):2-12.
    View in: PubMed
    Score: 0.017
  13. Expansions, contractions, and fragility of the spinocerebellar ataxia type 10 pentanucleotide repeat in yeast. Proc Natl Acad Sci U S A. 2011 Feb 15; 108(7):2843-8.
    View in: PubMed
    Score: 0.016
  14. Autoimmune recognition profile of the alpha chain of human acetylcholine receptor in myasthenia gravis. Adv Exp Med Biol. 1991; 303:255-61.
    View in: PubMed
    Score: 0.015
  15. Gene symbol: CLCN1. Disease: Myotonia congenita. Hum Genet. 2008 Feb; 123(1):104-5.
    View in: PubMed
    Score: 0.013
  16. Interruptions in the expanded ATTCT repeat of spinocerebellar ataxia type 10: repeat purity as a disease modifier? Am J Hum Genet. 2006 Jan; 78(1):125-9.
    View in: PubMed
    Score: 0.011
  17. Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90.
    View in: PubMed
    Score: 0.008
  18. Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. J Neuroimmunol. 2000 Jun 26; 105(2):131-44.
    View in: PubMed
    Score: 0.007
  19. Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of Myasthenia gravis? Hum Immunol. 2000 Mar; 61(3):255-65.
    View in: PubMed
    Score: 0.007
  20. Somatic sequence variation at the Friedreich ataxia locus includes complete contraction of the expanded GAA triplet repeat, significant length variation in serially passaged lymphoblasts and enhanced mutagenesis in the flanking sequence. Hum Mol Genet. 1999 Dec; 8(13):2425-36.
    View in: PubMed
    Score: 0.007
  21. Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet. 1997 May; 60(5):1251-6.
    View in: PubMed
    Score: 0.006
  22. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997 Jan; 15(1):62-9.
    View in: PubMed
    Score: 0.006
  23. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics. 1995 Jul 01; 28(1):1-14.
    View in: PubMed
    Score: 0.005
  24. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet. 1995 Jan; 4(1):1-8.
    View in: PubMed
    Score: 0.005
  25. Analysis of exposed regions on the main extracellular domain of mouse acetylcholine receptor alpha subunit in live muscle cells by binding profiles of antipeptide antibodies. J Protein Chem. 1994 Nov; 13(8):715-22.
    View in: PubMed
    Score: 0.005
  26. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science. 1993 Apr 09; 260(5105):235-8.
    View in: PubMed
    Score: 0.005
  27. cDNA surveying of specific tissue expression of human chromosome 19 sequences. Genomics. 1992 Oct; 14(2):263-9.
    View in: PubMed
    Score: 0.004
  28. Characterization of a YAC and cosmid contig containing markers tightly linked to the myotonic dystrophy locus on chromosome 19. Genomics. 1992 Jul; 13(3):526-31.
    View in: PubMed
    Score: 0.004
  29. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992 Mar 06; 255(5049):1256-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.